These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24218408)

  • 41. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
    Irvine MA; Stolk WA; Smith ME; Subramanian S; Singh BK; Weil GJ; Michael E; Hollingsworth TD
    Lancet Infect Dis; 2017 Apr; 17(4):451-458. PubMed ID: 28012943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
    McCarthy J
    Am J Trop Med Hyg; 2005 Aug; 73(2):232-3. PubMed ID: 16103580
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphedema in three previously Wuchereria bancrofti-endemic health districts in Mali after cessation of mass drug administration.
    Dolo H; Coulibaly YI; Konipo FN; Coulibaly SY; Doumbia SS; Sangare MB; Soumaoro L; Coulibaly ME; Diallo AA; Diarra Y; Sangare M; Doumbia S; Colebunders R; Nutman TB
    BMC Infect Dis; 2020 Jan; 20(1):48. PubMed ID: 31941448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
    Pion SDS; Chesnais CB; Weil GJ; Fischer PU; Missamou F; Boussinesq M
    Lancet Infect Dis; 2017 Jul; 17(7):763-769. PubMed ID: 28372977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global programme to eliminate lymphatic filariasis: progress report, 2016.
    Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
    [No Abstract]   [Full Text] [Related]  

  • 46. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
    Gunawardena GS; Ismail MM; Bradley MH; Karunaweera ND
    Ann Trop Med Parasitol; 2007 Jun; 101(4):335-41. PubMed ID: 17524248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.
    Ismail MM; Jayakody RL; Weil GJ; Fernando D; De Silva MS; De Silva GA; Balasooriya WK
    Trans R Soc Trop Med Hyg; 2001; 95(3):332-5. PubMed ID: 11491010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    Clin Infect Dis; 2021 Sep; 73(6):994-1002. PubMed ID: 33728462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
    Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
    Pion SDS; Chesnais CB; Awaca-Uvon NP; Vlaminck J; Abdou A; Kunyu-Shako B; Kuyangisa Simuna G; Tambwe JP; Weil GJ; Boussinesq M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008322. PubMed ID: 32574160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Albendazole for lymphatic filariasis.
    Addiss D; Critchley J; Ejere H; Garner P; Gelband H; Gamble C;
    Cochrane Database Syst Rev; 2004; (1):CD003753. PubMed ID: 14974034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole.
    Selve BP; Bwadua S; Misa M; James K; Usurup JP; Turner P; Melrose W; Yad W; Samuel R; Eddie C
    P N G Med J; 2000; 43(3-4):183-7. PubMed ID: 11939299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
    Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
    Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
    Shenoy RK; Dalia S; John A; Suma TK; Kumaraswami V
    Ann Trop Med Parasitol; 1999 Sep; 93(6):643-51. PubMed ID: 10707109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008106. PubMed ID: 32176703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
    Ottesen EA; Vijayasekaran V; Kumaraswami V; Perumal Pillai SV; Sadanandam A; Frederick S; Prabhakar R; Tripathy SP
    N Engl J Med; 1990 Apr; 322(16):1113-7. PubMed ID: 2181312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti.
    Richards FO; Eberhard ML; Bryan RT; McNeeley DF; Lammie PJ; McNeeley MB; Bernard Y; Hightower AW; Spencer HC
    Am J Trop Med Hyg; 1991 Jan; 44(1):3-10. PubMed ID: 1996738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa.
    Liang JL; King JD; Ichimori K; Handzel T; Pa'au M; Lammie PJ
    Am J Trop Med Hyg; 2008 Jun; 78(6):924-8. PubMed ID: 18541771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.